Printed from Voxsanity (voxsanity.com.au) — NCT06837038 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Parkinsons Disease
Parkinson's Disease Trial, By Invitation
NCT06837038
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged between 50 and 80 years old.
- People who have had one or more strokes (either a blockage or bleeding in the brain), with the most recent stroke happening at least 6 months ago.
- People who can walk on their own without a cane or walking aid, but have a noticeable unevenness or imbalance in their walking style.
- People whose walking speed falls within a specific range — between 0.4 and 0.8 metres per second (confirm with trial site).
- People with enough hearing, vision, and understanding to complete movement and physical function tests.
- People who are willing and able to take part in all study activities and have signed a consent form.
- People who are not currently receiving any other rehabilitation treatment.
- People aged between 50 and 80 years old who have been diagnosed with Parkinson's disease according to the Chinese Diagnostic Criteria for Parkinson's Disease (2016 edition).
- People with Parkinson's disease who have noticeable walking difficulties such as a hurried shuffling gait, episodes of being unable to start or continue walking (freezing), or very slow walking, but who can still walk independently without a cane or walking aid.
- People with Parkinson's disease at a disease stage rated as Hoehn-Yahr stage 2 to 4 (a scale used to measure how advanced Parkinson's symptoms are).
- People with Parkinson's disease whose walking speed falls within a specific range — between 0.4 and 0.8 metres per second (confirm with trial site).
- People with Parkinson's disease who have enough hearing, vision, and understanding to complete movement and physical function tests.
- People with Parkinson's disease who are willing and able to take part in all study activities and have signed a consent form.
- People with Parkinson's disease who are not currently receiving any other rehabilitation treatment.
- People aged between 50 and 80 years old who have a Parkinson's-like condition that is not primary Parkinson's disease — this includes conditions such as medication-induced Parkinsonism, multiple system atrophy, or Parkinsonism related to small vessel disease in the brain, among others.
- People with a Parkinson's-like condition who have noticeable walking difficulties such as a hurried shuffling gait, freezing of gait, or very slow walking, but who can still walk independently without a cane or walking aid.
- People with a Parkinson's-like condition whose walking speed falls within a specific range — between 0.4 and 0.8 metres per second (confirm with trial site).
- People with a Parkinson's-like condition who have enough hearing, vision, and understanding to complete movement and physical function tests.
- People with a Parkinson's-like condition who are willing and able to take part in all study activities and have signed a consent form.
- People with a Parkinson's-like condition who are not currently receiving any other rehabilitation treatment.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are unable to cooperate with physical movement and function tests.
- People with high blood pressure that is not under control.
- People who have had a heart attack within the past 3 months.
- People with bone or joint conditions that affect walking, such as a leg fracture within the past year, surgery on the lower back or leg joints, or serious joint deformities that significantly affect the ability to walk.
- People who, in addition to their stroke, also have other nervous system conditions that affect walking, such as myasthenia gravis or poliomyelitis.
- People with primary Parkinson's disease are not eligible under the stroke group criteria.
- People who are unable to cooperate with physical movement and function tests.
- People with high blood pressure that is not under control.
- People who have had a heart attack within the past 3 months.
- People with bone or joint conditions that affect walking, such as a leg fracture within the past year, surgery on the lower back or leg joints, or serious joint deformities that significantly affect the ability to walk.
- People with Parkinson's disease who also have other neurological conditions that affect walking, such as a history of stroke, myasthenia gravis, or poliomyelitis.
- People who are unable to cooperate with physical movement and function tests.
- People with high blood pressure that is not under control.
- People who have had a heart attack within the past 3 months.
- People with bone or joint conditions that affect walking, such as a leg fracture within the past year, surgery on the lower back or leg joints, or serious joint deformities that significantly affect the ability to walk.
- People with a Parkinson's-like condition who also have other neurological conditions that affect walking, such as a history of stroke, myasthenia gravis, or poliomyelitis.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
By Invitation
Phase
Not Applicable
Sponsor
YiCheng Zhu
Registry
ClinicalTrials.gov
Start date
1 December 2024
Est. completion
31 October 2025
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
🇨🇳 China
Primary endpoints
Gait speed
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.